Hanlim Pharmaceutical is a finished-dose manufacturer based in United States. It appears in 20 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), NPRA (MY) and NAFDAC (NG).
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 10 | None |
| NPRA (MY) | 4 | None |
| NAFDAC (NG) | 2 | None |
| NMPA (CN) | 2 | None |
| UZPHARM (UZ) | 2 | None |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Hanlim Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free